Article
Eye drug success mitigates Roche's earnings decline
Rating:
0.0
Views:
41
Likes:
1
Library:
1
Roche said first-half core operating profit fell 14% as the Swiss drugs and diagnostics maker was hit by a sharp decline in sales of COVID-19 products but the strong launch of a new eye drug mitigated the decline.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value